Table 1 Clinical characteristics of participants at baseline evaluation and description of observations.
CLINICAL | ||||||
|---|---|---|---|---|---|---|
S1 | S2 | S3 | S4 | S5 | All | |
Age | 72 | 73 | 78 | 79 | 85 | 77.4 ± 5.2 |
Diagnostic | Immob. Syndrome | Fractured femur | Fractured hip | Femoral amput. | Fractured hip Stroke | NA |
SMAF (0 to -87) | -35 | -30 | -38 | -19 | -40 | -32.4 ± 8.4 |
Berg (0–56) | 5 | 10 | 29 | 37 | 16 | 19.4 ± 13.3 |
TUG (sec) | * | 56.7 | 34.6 | 61.0 | 82.0 | 58.6 ± 19.4 |
5 m walk (sec) | * | 22.1 | 12.5 | * | 18.3 | 17.6 ± 4.8 |
OBSERVATIONS | ||||||
N of Sessions | 8 | 12 | 10 | 12 | 20 | 62 |
Total time (min) | 58.4 ± 9.1 | 52.0 ± 3.8 | 57.2 ± 12.1 | 43.5 ± 6.2 | 59.5 ± 8.7 | 47.8 ± 12.2 |
Active time (min) | 39.8 ± 11.3 | 33.2 ± 6.5 | 19.3 ± 9.3 | 33.0 ± 7.6 | 33.6 ± 9.9 | 27.0 ± 11.1 |
Density (%) | 67.8 ± 13.3 | 63.9 ± 12.0 | 34.1 ± 14.4 | 75.5 ± 11.5 | 48.2 ± 8.7 | 56.8 ± 18.1 |